Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.

Literature DB >> 22541416

Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.

Matthew C Bell, Daniel J Jackson.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2012 PMID： 22541416 PMCID： PMC3340573 DOI： 10.1016/j.anai.2012.02.021

Source DB: PubMed Journal: Ann Allergy Asthma Immunol ISSN： 1081-1206 Impact factor: 6.347

× No keyword cloud information.

8 in total

1. Mast cell activation syndrome: Proposed diagnostic criteria.

Authors: Cem Akin; Peter Valent; Dean D Metcalfe
Journal: J Allergy Clin Immunol Date: 2010-10-28 Impact factor: 10.793

Review 2. Anti-IgE as a mast cell-stabilizing therapeutic agent.

Authors: Tse Wen Chang; Yu-Yu Shiung
Journal: J Allergy Clin Immunol Date: 2006-05-11 Impact factor: 10.793

Review 3. Differential release of mast cell mediators and the pathogenesis of inflammation.

Authors: Theoharis C Theoharides; Duraisamy Kempuraj; Michael Tagen; Pio Conti; Dimitris Kalogeromitros
Journal: Immunol Rev Date: 2007-06 Impact factor: 12.988

4. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Authors: Melody C Carter; Jamie A Robyn; Peter B Bressler; John C Walker; Gail G Shapiro; Dean D Metcalfe
Journal: J Allergy Clin Immunol Date: 2007-05-03 Impact factor: 10.793

5. Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient.

Authors: J A Douglass; K Carroll; A Voskamp; P Bourke; A Wei; R E O'Hehir
Journal: Allergy Date: 2009-11-04 Impact factor: 13.146

6. Omalizumab treatment of systemic mast cell activation disease: experiences from four cases.

Authors: Gerhard J Molderings; Martin Raithel; Felix Kratz; Marc Azemar; Britta Haenisch; Sabrina Harzer; Jürgen Homann
Journal: Intern Med Date: 2011-03-15 Impact factor: 1.271

7. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay.

Authors: R Sargur; D Cowley; S Murng; G Wild; K Green; A Shrimpton; W Egner
Journal: Clin Exp Immunol Date: 2011-03 Impact factor: 4.330

Review 8. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.

Authors: Gerhard J Molderings; Stefan Brettner; Jürgen Homann; Lawrence B Afrin
Journal: J Hematol Oncol Date: 2011-03-22 Impact factor: 17.388

8 in total

13 in total

Review 1. Off-Label Uses of Omalizumab.

Authors: David El-Qutob
Journal: Clin Rev Allergy Immunol Date: 2016-02 Impact factor: 8.667

Review 2. Mast Cell Activation Syndrome.

Authors: Marianne Frieri
Journal: Clin Rev Allergy Immunol Date: 2018-06 Impact factor: 8.667

Review 3. Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors: Jay A Lieberman; Mirna Chehade
Journal: Curr Allergy Asthma Rep Date: 2013-02 Impact factor: 4.806

Review 4. Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review.

Authors: James S Pearson; Robert M Niven; Jie Meng; Sima Atarodi; Peter J Whorwell
Journal: Therap Adv Gastroenterol Date: 2015-09 Impact factor: 4.409

Review 5. Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors: Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal: Curr Allergy Asthma Rep Date: 2013-02 Impact factor: 4.806

6. Mast cell disorders: Protean manifestations and treatment responses.

Authors: Meng Chen; Alexander Kim; Bruce Zuraw; Taylor A Doherty; Sandra Christiansen
Journal: Ann Allergy Asthma Immunol Date: 2018-03-28 Impact factor: 6.347

7. The bee sting that was not: an unusual case of hymenoptera anaphylaxis averted in a patient treated with omalizumab for asthma.

Authors: Evelyn M Slaughter; Nathan Boyer; Steven Bennett
Journal: Case Rep Med Date: 2014-08-12